BridgeBio Oncology Therapeutics Inc. (BBOT) Revenue History
Annual and quarterly revenue from 2021 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
BBOT Revenue Growth
BBOT Revenue Analysis (2021–2025)
As of May 8, 2026, BridgeBio Oncology Therapeutics Inc. (BBOT) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q4 2025) recorded $0 in revenue.
Looking at the longer-term picture, BBOT's historical revenue data shows various trends over time.
When compared to Healthcare sector peers including BBIO (+344.2% YoY), KYMR (-12.6% YoY), and TPVG. Compare BBOT vs BBIO →
BBOT Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| BBOTCurrent | $0 | - | - | - | |
 BBIO | $502M | +344.2% | +127.4% | -113.3% | |
 KYMR | $39M | -12.6% | +2.9% | -891.3% | |
 TPVG | $97M | - | - | 77.9% | |
 KRYS | $389M | +25.1% | - | 41.5% |
BBOT Historical Revenue Data (2021–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | - | $0 | - | $-145,819,000 | - |
| 2024 | $0 | - | $0 | - | $-80,863,000 | - |
| 2023 | $0 | - | $0 | - | $-64,771,000 | - |
| 2022 | $0 | - | $0 | - | $-3,520 | - |
| 2021 | $0 | - | $0 | - | $-43,357 | - |
See BBOT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs BBOT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare BBOT vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonBBOT — Frequently Asked Questions
Quick answers to the most common questions about buying BBOT stock.
Is BBOT's revenue growth accelerating or slowing?
BBOT TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is BBOT's long-term revenue growth rate?
BridgeBio Oncology Therapeutics Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is BBOT's revenue distributed by segment?
BBOT reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2021-2025 are available for download. Segment mix reveals concentration and diversification trends.